Cargando…
Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS
Sauromatum giganteum (Engl.) Cusimano & Hett Tuber are used in Chinese folklore medicine for treatment of neoplasms. However, the claim has not been scientifically validated. The aim of the study is to screen the antitumor bioactive fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272407/ https://www.ncbi.nlm.nih.gov/pubmed/25756649 http://dx.doi.org/10.3390/molecules20034290 |
_version_ | 1783377149418274816 |
---|---|
author | Gao, Shi-Yong Gong, Yun-Fei Sun, Qiu-Jia Bai, Jing Wang, Long Fan, Zi-Quan Sun, Yu Su, Yi-Jun Gang, Jian Ji, Yu-Bin |
author_facet | Gao, Shi-Yong Gong, Yun-Fei Sun, Qiu-Jia Bai, Jing Wang, Long Fan, Zi-Quan Sun, Yu Su, Yi-Jun Gang, Jian Ji, Yu-Bin |
author_sort | Gao, Shi-Yong |
collection | PubMed |
description | Sauromatum giganteum (Engl.) Cusimano & Hett Tuber are used in Chinese folklore medicine for treatment of neoplasms. However, the claim has not been scientifically validated. The aim of the study is to screen the antitumor bioactive fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tuber and sensitive tumor cell lines using a cytotoxicity assay in vitro and tumor transplantation method in vivo, to support its use in folk medicine. The petroleum ether fraction, chloroform fraction, ethyl acetate fraction, n-butanol fraction and water fraction were successively extracted by turn by the maceration under reflux assay. Screening of antitumor bioactive fraction and sensitive cell lines were measured by MTT assay and the serum pharmacology method, and in vivo the antitumor activities of the active fraction was evaluated by using S(180) or H(22) tumor-bearing mice model and Kunming mice. The active constituents of ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett were characterized by UPLC-TOF-MS. Compared with control groups, mice serum containing ethyl acetate fraction had a inhibition effect on SMMC-7721 cell, SGC-7901 cell, MCF-7 cell, HeLa cell, A549 cell, HT-29, and MDA-MB-231, respectively, but mice serum containing other four fractions had no different with that of control group. The inhibition capabilities of mice serum containing ethyl acetate fraction on the seven cell lines in descending order is SGC-7901 > SMMC-7721 > MCF-7 > HT-29 > A549 > HeLa > MDA-MB-231. In vivo the inhibition rate of 106, 318, 954 mg/kg·d ethyl acetate fraction dry extract to sarcoma S(180) is 15.22%, 26.15% and 40.24%, respectively, and life prolonging rate to hepatoma H(22) is 33.61%, 40.16% and 55.74%. A total of 14 compounds were identified in the ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett. The results of the experimental studies proved the antitumor activity of Sauromatum giganteum (Engl.) Cusimano & Hett and supported the traditional use of this plant. These data indicate the potential for the use of ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tuber in tumor therapy, anti-tumor activity on cancer cell line in descending order is SGC-7901 > SMMC-7721 > MCF-7 > HT-29 > A549 > HeLa > MDA-MB-231. |
format | Online Article Text |
id | pubmed-6272407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62724072018-12-31 Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS Gao, Shi-Yong Gong, Yun-Fei Sun, Qiu-Jia Bai, Jing Wang, Long Fan, Zi-Quan Sun, Yu Su, Yi-Jun Gang, Jian Ji, Yu-Bin Molecules Article Sauromatum giganteum (Engl.) Cusimano & Hett Tuber are used in Chinese folklore medicine for treatment of neoplasms. However, the claim has not been scientifically validated. The aim of the study is to screen the antitumor bioactive fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tuber and sensitive tumor cell lines using a cytotoxicity assay in vitro and tumor transplantation method in vivo, to support its use in folk medicine. The petroleum ether fraction, chloroform fraction, ethyl acetate fraction, n-butanol fraction and water fraction were successively extracted by turn by the maceration under reflux assay. Screening of antitumor bioactive fraction and sensitive cell lines were measured by MTT assay and the serum pharmacology method, and in vivo the antitumor activities of the active fraction was evaluated by using S(180) or H(22) tumor-bearing mice model and Kunming mice. The active constituents of ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett were characterized by UPLC-TOF-MS. Compared with control groups, mice serum containing ethyl acetate fraction had a inhibition effect on SMMC-7721 cell, SGC-7901 cell, MCF-7 cell, HeLa cell, A549 cell, HT-29, and MDA-MB-231, respectively, but mice serum containing other four fractions had no different with that of control group. The inhibition capabilities of mice serum containing ethyl acetate fraction on the seven cell lines in descending order is SGC-7901 > SMMC-7721 > MCF-7 > HT-29 > A549 > HeLa > MDA-MB-231. In vivo the inhibition rate of 106, 318, 954 mg/kg·d ethyl acetate fraction dry extract to sarcoma S(180) is 15.22%, 26.15% and 40.24%, respectively, and life prolonging rate to hepatoma H(22) is 33.61%, 40.16% and 55.74%. A total of 14 compounds were identified in the ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett. The results of the experimental studies proved the antitumor activity of Sauromatum giganteum (Engl.) Cusimano & Hett and supported the traditional use of this plant. These data indicate the potential for the use of ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tuber in tumor therapy, anti-tumor activity on cancer cell line in descending order is SGC-7901 > SMMC-7721 > MCF-7 > HT-29 > A549 > HeLa > MDA-MB-231. MDPI 2015-03-06 /pmc/articles/PMC6272407/ /pubmed/25756649 http://dx.doi.org/10.3390/molecules20034290 Text en © 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gao, Shi-Yong Gong, Yun-Fei Sun, Qiu-Jia Bai, Jing Wang, Long Fan, Zi-Quan Sun, Yu Su, Yi-Jun Gang, Jian Ji, Yu-Bin Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS |
title | Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS |
title_full | Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS |
title_fullStr | Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS |
title_full_unstemmed | Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS |
title_short | Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS |
title_sort | screening antitumor bioactive fraction from sauromatum giganteum (engl.) cusimano & hett and sensitive cell lines with the serum pharmacology method and identification by uplc-tof-ms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272407/ https://www.ncbi.nlm.nih.gov/pubmed/25756649 http://dx.doi.org/10.3390/molecules20034290 |
work_keys_str_mv | AT gaoshiyong screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT gongyunfei screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT sunqiujia screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT baijing screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT wanglong screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT fanziquan screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT sunyu screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT suyijun screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT gangjian screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms AT jiyubin screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms |